Page last updated: 2024-08-23

epirubicin and Vascular Diseases

epirubicin has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Seiter, K	1
Gelmon, KA; Grant, DR; Norris, B; Pansegrau, GK	1

Reviews

1 review(s) available for epirubicin and Vascular Diseases

Article	Year
Toxicity of the topoisomerase II inhibitors. Expert opinion on drug safety, 2005, Volume: 4, Issue:2 Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases	2005

Other Studies

1 other study(ies) available for epirubicin and Vascular Diseases

Article	Year
Trastuzumab-associated peripheral vascular toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-10, Volume: 25, Issue:11 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arm; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Trastuzumab; Vascular Diseases	2007

Article

Year

Trastuzumab-associated peripheral vascular toxicity.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-10, Volume: 25, Issue:11

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arm; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Trastuzumab; Vascular Diseases

2007